Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Evolus, Inc. (EOLS)
Price$9.30Cached quote
Net income
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $297.2M | $266.3M | $202.1M | $148.6M | $99.7M | $56.5M | $34.9M | $0 | — |
| Gross profit | $197.1M | $182.3M | $137.6M | $89.8M | $56.1M | $38.2M | $26.9M | $0 | — |
| Gross margin | 66.33% | 68.46% | 68.08% | 60.41% | 56.32% | 67.64% | 77.05% | — | — |
| Research & development | $9.6M | $9.2M | $6.6M | $4.7M | $2.1M | $1.7M | $4.0M | $6.5M | $6.7M |
| Operating expenses | $229.8M | $216.7M | $251.3M | $213.9M | $144.1M | $209.6M | $133.9M | $46.1M | $11.7M |
| Operating income | −$32.7M | −$34.4M | −$49.2M | −$65.3M | −$44.4M | −$153.1M | −$98.9M | −$46.1M | −$11.7M |
| Operating margin | −10.99% | −12.92% | −24.36% | −43.96% | −44.55% | −270.73% | −283.31% | — | — |
| EBITDA | −$25.2M | −$29.1M | −$44.1M | −$61.6M | −$38.8M | −$146.0M | −$94.8M | −$46.1M | −$11.5M |
| EBITDA margin | −8.47% | −10.93% | −21.82% | −41.45% | −38.91% | −258.30% | −271.48% | — | — |
| Net income | −$51.6M | −$50.4M | −$61.7M | −$74.4M | −$46.8M | −$163.0M | −$90.0M | −$46.9M | −$4.5M |
| Net profit margin | −17.38% | −18.94% | −30.52% | −50.07% | −46.96% | −288.31% | −257.79% | — | — |
| Basic EPSper basic share | -$0.80 | -$0.81 | -$1.08 | -$1.33 | -$0.94 | -$4.83 | -$3.19 | -$1.92 | -$0.27 |
| Diluted EPSper diluted share | -$0.80 | -$0.81 | -$1.08 | -$1.33 | -$0.94 | -$4.83 | -$3.19 | -$1.92 | -$0.27 |
Owners
Reported shareholders
16.97%of listed shares
Nantahala Capital Management, LLC11.2M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Nantahala Capital Management, LLC | 16.97%11.2M shares |
BlackRock, Inc. | 7.33%4.84M shares |
BRAIDWELL LP | 4.78%3.16M shares |
Frazier Life Sciences Management, L.P. | 3.99%2.63M shares |
PERCEPTIVE ADVISORS LLC | 3.73%2.46M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.58%2.36M shares |
Assenagon Asset Management S.A. | 2.75%1.82M shares |
MILLENNIUM MANAGEMENT LLC | 2.71%1.79M shares |
STATE STREET CORP | 2.57%1.7M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.44%1.61M shares |
Stonepine Capital Management, LLC | 2.41%1.59M shares |
Point72 Asset Management, L.P. | 2.29%1.51M shares |
PINNACLE ASSOCIATES LTD | 2.25%1.49M shares |
ARMISTICE CAPITAL, LLC | 2.18%1.44M shares |
RICE HALL JAMES & ASSOCIATES, LLC | 1.95%1.29M shares |
AWH Capital, L.P. | 1.89%1.25M shares |
GOLDMAN SACHS GROUP INC | 1.85%1.22M shares |
Soleus Capital Management, L.P. | 1.25%822.43K shares |
Soviero Asset Management, LP | 1.17%770K shares |
UBS Group AG | 1.14%752.68K shares |
Percentages use 66.01M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 20, 2026Form 4 | Avelar RuiSee Remarks | SellCommon Stock | 3.1K | $4.75 | $14.8K | 427.4K |
| Mar 20, 2026Form 4 · 10b5-1 | MOATAZEDI DAVIDSee Remarks | SellCommon Stock | 13.7K | $4.75 | $64.9K | 604.7K |
| Mar 17, 2026Form 4 · 10b5-1 | MOATAZEDI DAVIDSee Remarks | SellCommon Stock | 116.7K | $4.89 | $570.8K | 618.4K |
| Mar 17, 2026Form 4 · 10b5-1 | Avelar RuiSee Remarks | SellCommon Stock | 30.0K | $4.89 | $146.7K | 430.5K |
| Dec 22, 2025Form 4 · 10b5-1 | MOATAZEDI DAVIDSee Remarks | SellCommon Stock | 10.5K | $7.15 | $75.4K | 354.4K |